The quest for successful therapies requires identification of novel therapeutic approaches. This review discusses recent advancements in identifying and validating such objectives – moving beyond conventional pathways to tackle unmet medical needs. Specifically , we investigate targets involved in multifaceted disease pathways, including malfunct